CSII Share Price

Open 24.14 Change Price %
High 24.26 1 Day -0.01 -0.04
Low 23.67 1 Week 0.00 0.00
Close 24.07 1 Month -3.68 -13.26
Volume 307595 1 Year -1.16 -4.60
52 Week High 33.11
52 Week Low 23.00
CSII Important Levels
Resistance 2 24.62
Resistance 1 24.39
Pivot 24.00
Support 1 23.75
Support 2 23.52
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
MU 44.31 6.39%
MU 44.31 6.39%
MU 44.31 6.39%
RIMM 13.03 0.39%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
SCHS 0.04 33.33%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
HLIT 3.70 25.42%
OTT 2.39 25.13%
QNST 8.90 20.76%
VRTA 4.00 19.40%
SNSS 2.56 19.07%
GCFB 0.44 18.92%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
GMETP 0.15 -76.92%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
More..

Cardiovascular Systems, Inc. (NASDAQ: CSII)

CSII Technical Analysis 5
As on 31st Oct 2017 CSII Share Price closed @ 24.07 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 28.54 & Strong Sell for SHORT-TERM with Stoploss of 28.37 we also expect STOCK to react on Following IMPORTANT LEVELS.
CSII Target for November
1st Target up-side 27.23
2nd Target up-side 29.45
3rd Target up-side 31.66
1st Target down-side 20.91
2nd Target down-side 18.69
3rd Target down-side 16.48
CSII Other Details
Segment EQ
Market Capital 249162480.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.csi360.com
CSII Address
CSII
651 Campus Drive
St. Paul, MN 55112-3495
United States
Phone: 651-259-1600
Fax: 612-677-3355
CSII Latest News
Interactive Technical Analysis Chart Cardiovascular Systems, Inc. ( CSII NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Cardiovascular Systems, Inc.
CSII Business Profile
Cardiovascular Systems, Inc. (CSI) is a medical device company. CSI is focused on developing and commercializing minimally invasive treatment solutions for vascular disease. Interventional endovascular treatment of peripheral artery disease (PAD) is the Company�s initial area of focus. The Company�s primary products include the Diamondback 360 PAD System (Diamondback 360), Diamondback Predator 360 PAD System (Predator 360) and Stealth 360 PAD System (Stealth 360). Diamondback 360, the Predator 360 and the Stealth 360 collectively are referred to as PAD Systems. As of June 30, 2011, the PAD Systems had been utilized in more than 50,000 procedures. It uses internally manufactured and externally sourced to manufacture the PAD Systems. In addition to the PAD Systems, CSI is expanding its product portfolio through internal product development and establishment of business relationships with other medical device companies.